|Awarded On||May 18, 2016|
|Title||Pathogenesis and Early Progression of Lung Cancer|
|Award Mechanism||Multi-Investigator Research Awards (Version 2)|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Ignacio Wistuba|
|Cancer Sites||Lung and Bronchus|
TITLE: Pathogenesis and Early Progression of Lung Cancer LAYPERSON’S SUMMARY In the United States, lung cancer is the leading cause of cancer, accounting for 30% of all cancer deaths. Texas is no exception, where lung cancer is equally sobering, due the state’s unique demographics and the high prevalence of smoking in minority populations. Indeed, global trends, particularly in the developing world, imply a continued economic and personal cost of great proportion. Yet, intriguingly, amidst this bleakness is an opportunity for a transformation in preventative medicine and clinical care, born from recent high-profile discoveries and revolutions in molecular biology, data science, and clinical ...